MedMira Valuation
| MIR Stock | CAD 0.10 0.01 9.09% |
MedMira seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of MedMira from analyzing the firm fundamentals such as Return On Asset of -0.26, shares owned by insiders of 68.95 %, and Current Valuation of 78.66 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting MedMira's valuation include:
Enterprise Value | Enterprise Value Ebitda (80.03) | Price Sales 196.8782 | Enterprise Value Revenue 220.6774 |
Overvalued
Today
Please note that MedMira's price fluctuation is out of control at this time. Calculation of the real value of MedMira is based on 3 months time horizon. Increasing MedMira's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MedMira stock is determined by what a typical buyer is willing to pay for full or partial control of MedMira. Since MedMira is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MedMira Stock. However, MedMira's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.0882 | Hype 0.1 |
The intrinsic value of MedMira's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MedMira's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MedMira helps investors to forecast how MedMira stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedMira more accurately as focusing exclusively on MedMira's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use MedMira's intrinsic value based on its ongoing forecasts of MedMira's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against MedMira's closest peers.
MedMira Cash |
|
MedMira Valuation Trend
Analysing the historical paterns of MedMira's enterprise value and its market capitalization is a good way to estimate and gauge the value of MedMira over time and is usually enough for investors to make rational market timing decisions.
MedMira Total Value Analysis
MedMira is now estimated to have takeover price of 78.66 M with market capitalization of 56.14 M, debt of 6.11 M, and cash on hands of 1.06 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MedMira fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
78.66 M | 56.14 M | 6.11 M | 1.06 K |
MedMira Investor Information
About 69.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. MedMira had not issued any dividends in recent years. Based on the key measurements obtained from MedMira's financial statements, MedMira may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.MedMira Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MedMira has an asset utilization ratio of 6.8 percent. This indicates that the Company is making C$0.068 for each dollar of assets. An increasing asset utilization means that MedMira is more efficient with each dollar of assets it utilizes for everyday operations.MedMira Ownership Allocation
MedMira maintains a total of 701.73 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.95 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.MedMira Profitability Analysis
The company reported the revenue of 412.57 K. Net Loss for the year was (3.33 M) with loss before overhead, payroll, taxes, and interest of (512.51 K).About MedMira Valuation
Our relative valuation model uses a comparative analysis of MedMira. We calculate exposure to MedMira's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MedMira's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 260.5 K | 247.4 K | |
| Pretax Profit Margin | (7.26) | (7.62) | |
| Operating Profit Margin | (5.61) | (5.89) | |
| Net Loss | (7.26) | (7.62) | |
| Gross Profit Margin | 0.49 | 0.52 |
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.